These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


300 related items for PubMed ID: 23935127

  • 1. Determinants of serum T4 and T3 at the time of diagnosis in nosological types of thyrotoxicosis: a population-based study.
    Carlé A, Knudsen N, Pedersen IB, Perrild H, Ovesen L, Rasmussen LB, Laurberg P.
    Eur J Endocrinol; 2013 Nov; 169(5):537-45. PubMed ID: 23935127
    [Abstract] [Full Text] [Related]

  • 2. Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.
    Amino N, Yabu Y, Miki T, Morimoto S, Kumahara Y, Mori H, Iwatani Y, Nishi K, Nakatani K, Miyai K.
    J Clin Endocrinol Metab; 1981 Jul; 53(1):113-6. PubMed ID: 6165731
    [Abstract] [Full Text] [Related]

  • 3. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ, Lee BW, Kim JY, Jung JH, Min YK, Lee MS, Lee MK, Kim KW, Chung JH.
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [Abstract] [Full Text] [Related]

  • 4. The odyssey of nontoxic nodular goiter (NTNG) in Greece under suppression therapy, and after improvement of iodine deficiency.
    Michalaki M, Kyriazopoulou V, Paraskevopoulou P, Vagenakis AG, Markou KB.
    Thyroid; 2008 Jun; 18(6):641-5. PubMed ID: 18578614
    [Abstract] [Full Text] [Related]

  • 5. Thyroid function and prevalence of anti-thyroperoxidase (TPO) and anti-thyroglobulin (Tg) antibodies in outpatients hospital setting in an area with sufficient iodine intake: influences of age and sex.
    Legakis I, Manousaki M, Detsi S, Nikita D.
    Acta Med Iran; 2013 Jun; 51(1):25-34. PubMed ID: 23456581
    [Abstract] [Full Text] [Related]

  • 6. Thyroxine toxicosis in patients with iodine induced thyrotoxicosis.
    Sobrinho LG, Limbert ES, Santos MA.
    J Clin Endocrinol Metab; 1977 Jul; 45(1):25-9. PubMed ID: 577497
    [Abstract] [Full Text] [Related]

  • 7. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J, Hosoya T, Naito N, Yoshimura H, Kohno Y, Tarutani O, Kuma K, Sakane S, Takeda K, Mozai T.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [Abstract] [Full Text] [Related]

  • 8. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
    Gedik O, Ozdemir T, Akalin S.
    Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765
    [Abstract] [Full Text] [Related]

  • 9. Serum cytokines in thyrotoxicosis.
    Siddiqi A, Monson JP, Wood DF, Besser GM, Burrin JM.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):435-9. PubMed ID: 10022397
    [Abstract] [Full Text] [Related]

  • 10. Effect of thyrotropin-releasing hormone on serum thyroid hormones: a study in the patients with untreated and treated Graves' disease and subacute thyroiditis.
    Sato A, Yamada T, Aizawa T, Ichikawa K, Komiya I, Takasu N, Takemura Y.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2173-7. PubMed ID: 7608274
    [Abstract] [Full Text] [Related]

  • 11. The association of insulin resistance with subclinical thyrotoxicosis.
    Rezzonico J, Niepomniszcze H, Rezzonico M, Pusiol E, Alberto M, Brenta G.
    Thyroid; 2011 Sep; 21(9):945-9. PubMed ID: 21834678
    [Abstract] [Full Text] [Related]

  • 12. [T3-thyrotoxicosis: incidence, significance and correlation with iodine intake].
    Konrády A.
    Orv Hetil; 2000 Feb 13; 141(7):337-40. PubMed ID: 10703222
    [Abstract] [Full Text] [Related]

  • 13. Differentiation of postpartum Graves' thyrotoxicosis from postpartum destructive thyrotoxicosis using antithyrotropin receptor antibodies and thyroid blood flow.
    Ide A, Amino N, Kang S, Yoshioka W, Kudo T, Nishihara E, Ito M, Nakamura H, Miyauchi A.
    Thyroid; 2014 Jun 13; 24(6):1027-31. PubMed ID: 24400892
    [Abstract] [Full Text] [Related]

  • 14. Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality.
    O'Sullivan AJ, Lewis M, Diamond T.
    Eur J Endocrinol; 2006 Apr 13; 154(4):533-6. PubMed ID: 16556715
    [Abstract] [Full Text] [Related]

  • 15. T4-thyrotoxicosis.
    Dorfman SG, Young RL.
    Arch Intern Med; 1978 Jun 13; 138(6):1016-7. PubMed ID: 580554
    [Abstract] [Full Text] [Related]

  • 16. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M, Koizumi Y, Aizawa T, Yamada T, Takahashi Y, Watanabe T, Kamoi K.
    J Clin Endocrinol Metab; 1988 Jan 13; 66(1):103-8. PubMed ID: 3121661
    [Abstract] [Full Text] [Related]

  • 17. [In vitro diagnosis of T3 thyrotoxicosis].
    Semenov VD.
    Med Radiol (Mosk); 1983 Jun 13; 28(6):72-5. PubMed ID: 6688114
    [Abstract] [Full Text] [Related]

  • 18. Relationships between serum thyrotropin, serum free thyroxine (T4), and 3,5,3'-triiodothyronine (T3) and the daily T4 and T3 production rates in euthyroid patients with multinodular goiter.
    Bregengård C, Kirkegaard C, Faber J, Poulsen S, Hasselstrøm K, Siersbaek-Nielsen K, Friis T.
    J Clin Endocrinol Metab; 1987 Aug 13; 65(2):258-61. PubMed ID: 3597707
    [Abstract] [Full Text] [Related]

  • 19. Lower serum free thyroxine (T4) levels in painless thyroiditis compared with Graves' disease despite similar serum total T4 levels.
    Shigemasa C, Abe K, Taniguchi S, Mitani Y, Ueda Y, Adachi T, Urabe K, Tanaka T, Yoshida A, Mashiba H.
    J Clin Endocrinol Metab; 1987 Aug 13; 65(2):359-63. PubMed ID: 3110204
    [Abstract] [Full Text] [Related]

  • 20. A case of thyroxine thyrotoxicosis.
    Blank MS, Tucci JR.
    Arch Intern Med; 1987 May 13; 147(5):863-4. PubMed ID: 3579439
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.